What is the current Artificial Vascular Implants market size?

The Artificial Vascular Implants market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Artificial Vascular Implants market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Artificial Vascular Implants market?

Key drivers include rising cardiovascular disease prevalence and advancements in medical technology.

What challenges does the Artificial Vascular Implants market face?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the Artificial Vascular Implants market?

North America and Europe are currently leading the market due to strong healthcare infrastructure.

Who are the top companies in the Artificial Vascular Implants market?

Top companies include Medtronic, Boston Scientific, and Abbott Laboratories, driving innovation.

What future opportunities exist in the Artificial Vascular Implants market?

Emerging markets and technological advancements offer significant future outlook and growth potential.

How is technology impacting the Artificial Vascular Implants market?

Advances in biomaterials and 3D printing are improving implant design and functionality.

What is the current regulatory landscape for Artificial Vascular Implants?

Regulatory bodies such as FDA and CE enforce strict guidelines to ensure implant safety and efficacy.

What is the future outlook for the Artificial Vascular Implants market?

The market is expected to experience significant growth, driven by increasing demand and innovation.

Artificial Vascular Implants Size, Share & Forecast Analysis 2025–2033

Artificial Vascular Implants by Application (Aortic Disease, Peripheral Artery Disease, Hemodialysis), by Types (EPTFE, Polyethylene Terephthalate, Polyurethane, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Artificial Vascular Implants Market Overview

The Artificial Vascular Implants market refers to the industry that develops and manufactures artificial vascular implants, which are medical devices used to replace or support damaged or diseased blood vessels. The relevance of this market lies in its potential to improve the quality of life for patients with vascular diseases. As the Artificial Vascular Implants market size is estimated to be around $1.4 billion, the growth outlook and market forecast indicate a significant industry expansion, driven by advancements in vascular implant technology and an increasing demand for minimally invasive procedures. The scope of this market encompasses various types of implants, including coronary artery bypass grafts, peripheral vascular implants, and neurovascular implants, with applications in hospitals, clinics, and research institutions.

Loading chart…

The current market size is driven by a growth forecast with a CAGR of around 7.5%, and macro drivers such as an aging population, an increasing prevalence of vascular diseases, and advancements in medical technology. Key forces shaping the industry include technology shifts towards more minimally invasive procedures, regulations regarding the approval and commercialization of new implants, and competitive intensity among market players. The largest region in the Artificial Vascular Implants market is North America, while the fastest-growing region is expected to be the Asia-Pacific region. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to make strategic decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	8.60 million
Revenue forecast in 2033	15.68 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Maquet Cardiovascular; Terumo Group; Gore; B. Braun; Bard; Jotec GmbH; LeMaitre Vascular; Perouse Medical; Nicast; ShangHai CHEST; SuoKang
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Artificial Vascular Implants market is poised for significant growth, driven by advancing technologies and increasing demand for minimally invasive procedures. This section delves into the market dynamics shaping the Artificial Vascular Implants market size and growth forecast.

Growth Drivers2 items

Advancements in biomaterials and 3D printing technologies are expanding the scope of Artificial Vascular Implants, enabling the creation of customized implants that mimic the properties of natural blood vessels, thereby improving patient outcomes and driving market growth.

The rising prevalence of cardiovascular diseases and the growing need for effective treatment options are fueling the demand for Artificial Vascular Implants, contributing to the positive growth forecast of the Artificial Vascular Implants market.

Restraints2 items

High development costs and stringent regulatory requirements are significant barriers to entry for new players in the Artificial Vascular Implants market, potentially limiting market growth and innovation.

The risk of implant rejection and complications associated with Artificial Vascular Implants can hinder market adoption, emphasizing the need for ongoing research and development to improve implant safety and efficacy.

Opportunities2 items

The increasing adoption of Artificial Vascular Implants in emerging economies presents a significant opportunity for market expansion, driven by growing healthcare infrastructure and rising demand for advanced medical treatments.

Collaborations between manufacturers, researchers, and healthcare providers can facilitate the development of innovative Artificial Vascular Implants, addressing unmet clinical needs and driving growth in the Artificial Vascular Implants market.

Challenges2 items

Ensuring the long-term durability and biocompatibility of Artificial Vascular Implants remains a significant challenge, necessitating ongoing investment in research and development to improve implant materials and design.

The Artificial Vascular Implants market is subject to intense competition and pricing pressure, requiring manufacturers to balance innovation with cost-effectiveness to maintain market share and drive growth.

Market Segmentation

Loading chart…

The Artificial Vascular Implants market can be segmented based on application, which plays a crucial role in determining the overall market size. The application segment includes coronary artery disease, peripheral artery disease, and neurovascular disease, among others. Each application contributes to the Artificial Vascular Implants segmentation by catering to specific patient needs, thereby driving the demand for these implants.

In terms of types, the Artificial Vascular Implants market can be divided into subtypes such as stent grafts, vascular access devices, and implantable ports. These subtypes are designed to address various vascular conditions, and their adoption rates vary based on factors like disease prevalence, treatment efficacy, and patient preference. Understanding these subtypes is essential for market taxonomy, as it helps stakeholders identify growth opportunities and develop targeted strategies.

Artificial Vascular Implants Segmentation Breakdown9 items

Application

Aortic Disease

Peripheral Artery Disease

Hemodialysis

Types

EPTFE

Polyethylene Terephthalate

Polyurethane

Others

Regional Insights

Loading chart…

The Artificial Vascular Implants market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and significant investments in research and development. Europe is driven by a strong infrastructure, favorable policies, and a high level of adoption of advanced medical technologies. Asia Pacific is driven by a large and growing population, increasing adoption of advanced medical technologies, and significant investments in healthcare infrastructure. Latin America is driven by a growing population, increasing adoption of advanced medical technologies, and improving infrastructure. Middle East & Africa is driven by a growing population, increasing adoption of advanced medical technologies, and significant investments in healthcare infrastructure.

Regional Drivers5 items

North America: mature ecosystem, high demographics awareness, significant investments in research and development

Europe: strong infrastructure, favorable policies, high adoption of advanced medical technologies

Asia Pacific: large and growing population, increasing adoption of advanced medical technologies, significant investments in healthcare infrastructure

Latin America: growing population, increasing adoption of advanced medical technologies, improving infrastructure

Middle East & Africa: growing population, increasing adoption of advanced medical technologies, significant investments in healthcare infrastructure

Competitive Landscape

The Artificial Vascular Implants market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Artificial Vascular Implants competitive landscape is driven by the ability of companies to balance these levers and adapt to changing market conditions. Global players tend to dominate the market, but local companies are also gaining traction through targeted product offerings and regional partnerships.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are focusing on strategic initiatives to stay ahead in the market, as outlined below:

Maquet Cardiovascular: regional expansion

Terumo Group: innovation pipeline

Gore: premium pricing

B. Braun: local manufacturing

Bard: OEM tie-ups

Jotec GmbH: vertical integration

Key Artificial Vascular Implants Companies11 items

Maquet Cardiovascular

Terumo Group

Gore

B. Braun

Bard

Jotec GmbH

LeMaitre Vascular

Perouse Medical

Nicast

ShangHai CHEST

SuoKang

Market Ecosystem

The Artificial Vascular Implants ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of artificial vascular implants. The ecosystem boundaries are defined by the interactions between these segments, influencing how value is created and captured.

Raw material suppliers — providing biomaterials

OEMs / manufacturers — designing and producing implants

Technology providers — developing implantable technologies

System integrators / EPCs — integrating implant systems

Distributors / channel partners — supplying implants to hospitals

Regulators/standards bodies — setting implant safety standards

End users / buyers — purchasing and utilizing implants

In the Artificial Vascular Implants ecosystem, control points are largely influenced by regulators and standards bodies, as they dictate the safety and efficacy requirements for implant adoption. Dependency risks arise from input constraints, such as the availability of biomaterials, and approvals from regulatory bodies. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem. Furthermore, a value chain analysis of this ecosystem reveals that regional differences in regulatory frameworks and healthcare systems can lead to variations in the ecosystem's structure and dynamics.

Recent Industry Insights

The Artificial Vascular Implants industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product portfolios and expanding market reach. Notable mergers and acquisitions have also taken place, aiming to consolidate market position and drive innovation. Furthermore, several product and technology launches have been observed, showcasing advancements in implant design, material science, and minimally invasive procedures. Regulatory changes have also played a crucial role, with updated guidelines influencing the development and approval of artificial vascular implants. A shift in consumer trends towards minimally invasive and personalized treatments has been noted, driving the demand for advanced implant solutions. Additionally, funding rounds and expansions have been secured by various companies to support research and development initiatives, underscoring the industry's growth potential.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Artificial Vascular Implants market outlook. The market attractiveness is high due to the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios.

The long-term outlook for the Artificial Vascular Implants market is positive, driven by advancements in technology and the rising adoption of these implants in emerging economies. The innovation landscape is rapidly evolving, with a focus on developing more biocompatible and durable materials. However, the demand–supply balance is a key risk factor, as the market is highly dependent on the availability of skilled healthcare professionals and the regulatory environment. Overall, the Artificial Vascular Implants market is expected to experience significant growth, with key players investing heavily in research and development to address the growing demand for these implants.

12 items

1. Executive Summary

2. Artificial Vascular Implants Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Artificial Vascular Implants Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Artificial Vascular Implants Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Artificial Vascular Implants Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Artificial Vascular Implants Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Artificial Vascular Implants Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Artificial Vascular Implants Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Artificial Vascular Implants Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Artificial Vascular Implants Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Artificial Vascular Implants Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Artificial Vascular Implants Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Artificial Vascular Implants Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Artificial Vascular Implants Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Artificial Vascular Implants Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Artificial Vascular Implants Market Competition by Key Manufacturers

9.1. Global Artificial Vascular Implants Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Artificial Vascular Implants: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Maquet Cardiovascular

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo Group

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Gore

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. B. Braun

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bard

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Jotec GmbH

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. LeMaitre Vascular

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Perouse Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Nicast

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ShangHai CHEST

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. SuoKang

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Artificial Vascular Implants Market

Figure 4: Global Artificial Vascular Implants Market: Drivers

Figure 5: Global Artificial Vascular Implants Market: Challenges

Figure 6: Global Artificial Vascular Implants Market: Trends

Figure 7: Global Artificial Vascular Implants Market: Opportunity

Figure 8: Global Artificial Vascular Implants Market: Restraint

Figure 9: Global Artificial Vascular Implants Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Artificial Vascular Implants Market Value (USD Million) By Region

Figure 19: Global Artificial Vascular Implants Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Artificial Vascular Implants Market Value (USD Million) By Region

Figure 27: Global Artificial Vascular Implants Market Share (%) By: Regions (2032)

Figure 28: Global Artificial Vascular Implants Market Volume (K) By Region

Figure 29: Global Artificial Vascular Implants Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Artificial Vascular Implants Market Value (USD Million) By Region

Figure 37: Global Artificial Vascular Implants Market Share (%) By: Regions (2032)

Figure 38: Global Artificial Vascular Implants Market Volume (K) By Region

Figure 39: Global Artificial Vascular Implants Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Artificial Vascular Implants Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Artificial Vascular Implants Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Artificial Vascular Implants Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Artificial Vascular Implants Market Value (USD Million) By Region

Table 14: Global Artificial Vascular Implants Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Artificial Vascular Implants Market Volume (K) By Region

Table 31: Global Artificial Vascular Implants Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Artificial Vascular Implants Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Artificial Vascular Implants Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Artificial Vascular Implants Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Maquet Cardiovascular Basic Information And Sales Area

Table 52: Maquet Cardiovascular. Products Portfolio

Table 53: Terumo Group Basic Information And Sales Area

Table 54: Terumo Group. Products Portfolio

Table 55: Gore Basic Information And Sales Area

Table 56: Gore. Products Portfolio

Table 57: B. Braun Basic Information And Sales Area

Table 58: B. Braun. Products Portfolio

Table 59: Bard Basic Information And Sales Area

Table 60: Bard. Products Portfolio

Table 61: Jotec GmbH Basic Information And Sales Area

Table 62: Jotec GmbH. Products Portfolio

Table 63: LeMaitre Vascular Basic Information And Sales Area

Table 64: LeMaitre Vascular. Products Portfolio

Table 65: Perouse Medical Basic Information And Sales Area

Table 66: Perouse Medical. Products Portfolio

Table 67: Nicast Basic Information And Sales Area

Table 68: Nicast. Products Portfolio

Table 69: ShangHai CHEST Basic Information And Sales Area

Table 70: ShangHai CHEST. Products Portfolio

Table 71: SuoKang Basic Information And Sales Area

Table 72: SuoKang. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Artificial Vascular Implants Market Value (USD Million) By Region

Table 82: Global Artificial Vascular Implants Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Artificial Vascular Implants Market Volume (K) By Region

Table 99: Global Artificial Vascular Implants Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Artificial Vascular Implants Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.60 million
Revenue forecast in 2033	15.68 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Maquet Cardiovascular; Terumo Group; Gore; B. Braun; Bard; Jotec GmbH; LeMaitre Vascular; Perouse Medical; Nicast; ShangHai CHEST; SuoKang
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Artificial Vascular Implants Segmentation Breakdown9 items

Application

Aortic Disease

Peripheral Artery Disease

Hemodialysis

Types

EPTFE

Polyethylene Terephthalate

Polyurethane

Others

Regional Insights

Loading chart…

Regional Drivers5 items

North America: mature ecosystem, high demographics awareness, significant investments in research and development

Europe: strong infrastructure, favorable policies, high adoption of advanced medical technologies

Asia Pacific: large and growing population, increasing adoption of advanced medical technologies, significant investments in healthcare infrastructure

Latin America: growing population, increasing adoption of advanced medical technologies, improving infrastructure

Middle East & Africa: growing population, increasing adoption of advanced medical technologies, significant investments in healthcare infrastructure

Competitive Landscape

Maquet Cardiovascular: regional expansion

Terumo Group: innovation pipeline

Gore: premium pricing

B. Braun: local manufacturing

Bard: OEM tie-ups

Jotec GmbH: vertical integration

Key Artificial Vascular Implants Companies11 items

Maquet Cardiovascular

Terumo Group

Gore

B. Braun

Bard

Jotec GmbH

LeMaitre Vascular

Perouse Medical

Nicast

ShangHai CHEST

SuoKang

Market Ecosystem

Raw material suppliers — providing biomaterials

OEMs / manufacturers — designing and producing implants

Technology providers — developing implantable technologies

System integrators / EPCs — integrating implant systems

Distributors / channel partners — supplying implants to hospitals

Regulators/standards bodies — setting implant safety standards

End users / buyers — purchasing and utilizing implants

Recent Industry Insights

Analyst Overview

Table of Contents